Yvan Butera

Datos Biográficos

ID9799093
NOMBREYvan Butera
NOMBRESYvan
APELLIDOButera
FIRMABUTERA Y
AFILIACIONESRwanda Biomedical Center
ORCID0000-0002-0648-2384
VERIFICADOSí
TOTAL DE OBRAS2
TOTAL DE CITAS0
TOTAL COMO AUTOR2
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2024
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Strategies for mitigating emerging artemisinin-based antimalarial drug resistance in Rwanda

    Open AccessClaude Mambo Muvunyi, Pierre Gashema et al.ARTICLEBMJ Global Health2025

    Malaria treatment failures associated with reduced efficacy of chloroquine (CQ) and amodiaquine (AQ) antimalarial drugs emerged in Rwanda during the 1980s, prompting the policy shift towards adopting artemisinin-based combination therapies in 2006 as an alternative. However, recent findings from malaria surveillance and therapeutic efficacy studies have revealed a countrywide increase in antimalarial drug resistance. Particularly, artemether-lume…

  • South-to-south collaboration to strengthen the health workforce

    Open AccessYayehyirad Ejigu, Yayehyirad M Ejigu et al.ARTICLEBMJ Global Health2024

    Paediatric cardiovascular diseases have been referred to as diseases of injustice as access to care is inequitable globally. For example, Africa only has 78 cardiac centres, with 22 located in Sub-Saharan Africa. Most of these centres rely on visiting surgical teams to provide clinical care. While visiting surgical teams provide essential care, building a sustainable and locally run cardiac workforce in Africa is critical to addressing these ineq…